About 1Drop Diagnostics
1Drop Diagnostics is a company based in Neuchatel (Switzerland) founded in 2012. 1Drop Diagnostics has raised $7.75 million across 6 funding rounds from investors including Christian Wildmoser, Hans-Peter Strebel and Beat Schillig. 1Drop Diagnostics offers products and services including Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader. 1Drop Diagnostics operates in a competitive market with competitors including SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.
- Headquarter Neuchatel, Switzerland
- SectorsHealthcare
- Website 1dropdx.com
- Social LinkedIn X Facebook
- Legal Name 1Drop Sa
- Total Equity Funding$7.75M (USD)
in 6 rounds
- Latest Funding Round$4.25M (USD), Series A
Oct 2018
- InvestorsVenturelab
& 8 more
Products & Services of 1Drop Diagnostics
1Drop Diagnostics offers a comprehensive portfolio of products and services, including Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader.
Assesses risk of heart disease via high-sensitivity CRP biomarker.
Evaluates cardiovascular risk beyond traditional cholesterol measures.
Checks blood sugar control and diabetes development risk.
Detects underdiagnosed kidney disease through function analysis.
Analyzes blood samples for multiple biomarkers in minutes.
Funding Insights of 1Drop Diagnostics
1Drop Diagnostics has successfully raised a total of $7.75M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $4.25 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.75M
- Total Rounds 6
- Last Round Series A — $4.25M
- Investors Count 9
All 6 funding rounds of 1Drop Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2018 | $4.25M | Series A | – | Christian Wildmoser | |
| Apr 2016 | $3.5M | Series A | – | – | – |
| Feb 2016 | – | Seed | – | – | |
| Jun 2015 | $107,116 | Grant | – | – | |
| Oct 2014 | $316,850 | Grant | – | – | |
| May 2014 | – | Grant | – | – |
9 investors in total: 5 institutional and 4 angel.
Investors in 1Drop Diagnostics
1Drop Diagnostics has secured backing from 9 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Christian Wildmoser, Hans-Peter Strebel and Beat Schillig.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startup acceleration programs are operated across sectors to support growth. | – | venturelab.swiss | Schlieren, Switzerland | |
Early-stage entrepreneurs are accelerated through MassChallenge's program. | – | masschallenge.org | Boston, United States | |
Blackbox is focused on elevating entrepreneurs through global connections. | – | blackbox.org | Silicon Valley, USA | |
Startup awards are provided to support Swiss entrepreneurs. | – | devigier.ch | Solothurn, Switzerland | |
A regional bank in Neuchâtel supporting innovation through awards. | – | prix-bcn-innovation.ch | Neuchâtel, Switzerland | |
CW Christian Wildmoser | - | – | unknown_2ccc790ba0e74e809 | - |
HS Hans-Peter Strebel | - | – | unknown_9c9f14057f6b4cddb | - |
BS Beat Schillig | Swiss angel investor in Indian startups, focused on tech and innovation. | – | unknown_990e753716324832a | - |
JD Jean-Philippe De Toledo | - | – | unknown_2916b2862927424da | - |
Investor details for 1Drop Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of 1Drop Diagnostics
10 people are tracked at 1Drop Diagnostics (2 in leadership, 8 in board & advisors).
| Name | Role | Group |
|---|---|---|
Joerg Ziegler | Co Founder, CTO | Leadership |
Jörg Ziegler | Co-Founder & CTO | Leadership |
Nico De Rooij | Scientific Advisor | Board & advisors |
Markus Ehrat | Scientific Advisor | Board & advisors |
Hans Peter Herzig | Scientific Advisor | Board & advisors |
Per Magnus Kristiansen | Scientific Advisor | Board & advisors |
Daniel Lew | Medical Advisor | Board & advisors |
Vladimir Velebit | Medical Advisor | Board & advisors |
Benjamin Crocker | Medical Advisor | Board & advisors |
Kent Lewandrowski | Medical Advisor | Board & advisors |
Complete people profiles for 1Drop Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of 1Drop Diagnostics
3 dated milestones of 1Drop Diagnostics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded 1Drop Diagnostics is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $4.2M.
Competitors of 1Drop Diagnostics
1Drop Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| genincode.com | 2018 | Manchester, United Kingdom | $4.48M | 26 | Genetic and clinical data are integrated for precision cardiac medicines. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| realviewimaging.com | 2008 | Yokneam Illit, Israel | $25M | – | 3D holographic display solutions for medical imaging are provided. | |
| lepumedical.com | 1999 | Beijing, China | – | – | Interventional cardiology devices are developed and marketed globally. | |
| diadexus.com | 1997 | San Francisco, United States | $49.2M | – | Molecular diagnostic tests for cardiovascular disorders are developed and marketed. | |
| bostonheartdiagnostics.com | 2007 | Framingham, United States | $10.34M | – | Diagnostics for personalized cardiovascular disease management are developed. | |
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | – | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. | |
| spectrum-dynamics.com | 2000 | Morges, Switzerland | – | – | Cardiac imaging systems are manufactured using advanced molecular technologies. | |
| proximdx.com | 2010 | Sunnyvale, United States | $22.9M | – | Handheld immunodiagnostic devices for cardiac vascular diseases are developed. |
Detailed competitors of 1Drop Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 1Drop Diagnostics
The website of 1Drop Diagnostics (1dropdx.com) receives about 4.3K visits a month.
- Monthly visits4.3K
▲ 27.1% vs previous month
Similar companies to 1Drop Diagnostics
10 companies that operate in the same segment as 1Drop Diagnostics (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 1Drop Diagnostics
1Drop Diagnostics was founded in 2012 and raised its 1st funding round 2 years after it was founded.
1Drop Diagnostics is headquartered in Neuchatel, Switzerland.
1Drop Diagnostics is a funded company, having raised a total of $7.75M across 6 funding rounds to date.
1Drop Diagnostics was founded in 2012 in Neuchatel, Switzerland, within the health technology sector. Point-of-care diagnostic solutions are offered through finger-prick blood sampling. Lab-on-chip microfluidic technology is utilized to process small blood volumes, while advanced photonics detects fluorescence from immunoassays. Initial focus is placed on cardiovascular health, with biomarkers including NT-proBNP, D-Dimer, Troponin, and C-reactive protein. Operations emphasize accessible testing in clinical settings.
1Drop Diagnostics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
1Drop Diagnostics offers Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader.
1Drop Diagnostics has 9 investors. Key investors include Christian Wildmoser, Hans-Peter Strebel, Beat Schillig, Jean-Philippe De Toledo, and Venturelab.
1Drop Diagnostics operates through 1Drop Sa.